Ultrasound-Guided Microwave Ablation for Small RAS-Mutated Thyroid Nodules: A Pilot Study

23 patients with small RAS-mutated thyroid nodules treated with microwave ablation, with data on nodule volume and adverse events collected between February 2022 and July 2024. The study, authored by Fengyun Cheng, reports a median volume reduction rate of 11.84% at 12 months and 100% at 24 months for a subset of patients.

Use Cases

• Analyzing the efficacy of microwave ablation based on volume reduction rates reported in the study.
• Studying factors affecting treatment outcomes based on nodule diameter and volume data.
• Evaluating short-term safety profiles based on the reported adverse events data.
• Exploring predictors of complete regression based on the ROC analysis for diameter cut-offs mentioned.

Strengths

• Includes longitudinal data with a minimum 12-month follow-up for all 23 patients.
• Reports specific clinical metrics, including median preoperative diameter (6.20 mm) and volume (81.16 mm³).
• Data collection period is explicitly defined as February 2022 to July 2024.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is very small at 20.4 KB, indicating limited scope.

Provenance

Source

figshare, author Fengyun Cheng

Collection Method

Retrospective study of patient records.

Time Range

Data collected between February 2022 and July 2024.

Freshness

Last updated 2026-04-22 10:59:13; freshness should be verified.